e-learning
resources
Munich 2006
Tuesday 05.09.2006
Pulmonary rehabilitation and skeletal muscles, COPD and non-COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and importance of skeletal muscle weakness in cystic fibrosis
T. Troosters, B. Vrijsen, R. Gosselink, L. Dupont, M. Decramer (Leuven, Belgium)
Source:
Annual Congress 2006 - Pulmonary rehabilitation and skeletal muscles, COPD and non-COPD
Session:
Pulmonary rehabilitation and skeletal muscles, COPD and non-COPD
Session type:
Poster Discussion
Number:
3680
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Troosters, B. Vrijsen, R. Gosselink, L. Dupont, M. Decramer (Leuven, Belgium). Prevalence and importance of skeletal muscle weakness in cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 3680
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Does cystic fibrosis impact skeletal muscles and diaphragm function?
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Skeletal muscle function and structure in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016
Quadriceps muscle contractility and fatigability in cystic fibrosis (CF) patients
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Skeletal muscle metabolism in active cystic fibrosis (CF) patients with light/moderate pulmonary dysfunction
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis
Source: Eur Respir J 2009; 33: 99-106
Year: 2009
The impact of an acute exacerbation on physical activity and skeletal muscle force in patients with cystic fibrosis
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009
Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters
Source: Eur Respir J 2004; 23: 703-707
Year: 2004
In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD
Source: Eur Respir J 2003; 21: 273-278
Year: 2003
Ultrasound diaphragm activity in patients with cystic fibrosis: relationship to disease severity and peripheral muscle strength
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Exacerbation frequency and longitudinal changes in muscle strength in patients with cystic fibrosis
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009
Preferential lower limb muscle weakness in idiopathic pulmonary fibrosis: Effects on exercise capacity
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014
The clinical impact of skeletal muscle dysfunction
Source: Annual Congress 2008 - PG3 - Respiratory physiology: respiratory and peripheral muscle function in health and disease
Year: 2008
Relationship between respiratory muscle strength and pulmonary function in children with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 730s
Year: 2006
Hypogonadism is related to skeletal muscle weakness in male patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 256s
Year: 2004
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Pectoralis muscle area and skeletal muscle strength in patients with ILD
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006
Quadriceps wasting and physical inactivity in patients with COPD
Source: Eur Respir J 2012; 40: 1115-1122
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept